NOV 30, 2015 1:10 PM PST

New Test Finds Hidden Pancreatic Cancer Cells, Improves Treatment

WRITTEN BY: Xuan Pham
Pancreatic cancer has one of the worst mortality rates of all cancer types, largely because the cancer spreads rapidly and is seldom detected in its early stages. But researchers at the University of Chicago have found that sampling blood from the portal vein is more sensitive at detecting the cancer’s presence. This method may help doctors to diagnose pancreatic cancer earlier, providing a means to increase prognosis for this disease.
 
Blood taken from the portal vein detects higher tumor cell counts.

In the recent years, scientists have known that tumors can shed cancerous cells from the primary site into the patient’s bloodstream. They call these circulating tumor cells (CTCs), and have leveraged CTC’s presence to create detection methods for a wide range of cancers. Currently, the detection method for pancreatic cancer relies on blood taken from traditional arm venipunctures. However, researchers at the University of Chicago have challenged the sensitivity of this method.

The researchers reasoned that because of the large and irregular shape of CTCs, these cells can get trapped in small vessels before showing up in the bloodstream. So they devised a collection method where blood was taken from the portal vein, the main vessel that drains blood from the gastrointestinal tract and spleen to the liver. Compared to blood taken from the arm, portal vein blood showed much higher sensitivity at detecting tumor cell counts.

"This is a novel and far more sensitive way to acquire, enumerate, and characterize CTCs from pancreatobiliary and other gastrointestinal cancers in this setting.” Dr. Irving Waxman, senior study author.

 In 18 patients with suspected tumors in the pancreas and bile ducts, portal vein sampling detected CTCs for all 100% of patients. In contrast, tumor cells were only detected for 22% of patients with the traditional peripheral blood sampling method. Additionally, they found that the portal vein contained an abundance of CTCs for all cancer stages, including the hard-to-detect early stages. For every 7.5 milliliters of blood, more than 100 tumor cells were detected with portal vein blood samples, compared ~ 1 tumor cell for peripheral blood samples.

This new sampling method will be especially beneficial for early diagnosis of pancreatic cancer. According to the National Cancer Institute, the five-year survival rate for pancreatic cancer is only 7.2%. The disease is so deadly because signs and symptoms don’t appear until the cancer is quite advanced. By such point, the cancer has likely metastasized and surgical removal is not effective. However, with this method, the cancer can be detected early enough where removal is still possible.

"In the setting of localized cancer where these findings are most applicable, the additional information of portal vein CTC number and their molecular characterization may help predict who will benefit from aggressive therapy before surgery, who is most at risk for a recurrence after the operation, and even who will not benefit from surgery at all." Dr. Daniel Catenacci, co-first author of the study.

Watch the video to learn more about pancreatic cancer.
 

Sources: Gastroenterology, Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 03, 2020
Genetics & Genomics
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
NOV 03, 2020
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
JAN 19, 2021
Cardiology
Looking to the Immune System for Help Diagnosing Carotid Stenosis
JAN 19, 2021
Looking to the Immune System for Help Diagnosing Carotid Stenosis
Everyone has seen a commercial about how bad fats can build up into a plaque into a blood vessel. This is called atheros ...
FEB 04, 2021
Clinical & Molecular DX
Neurological and Psychiatric Aftershocks of the Pandemic
FEB 04, 2021
Neurological and Psychiatric Aftershocks of the Pandemic
One in eight COVID-19 survivors have received a diagnosis of a neurological or psychiatric condition in the year followi ...
MAR 02, 2021
Cardiology
Creating a Light Switch in the Heart to Regulate Heart Rate
MAR 02, 2021
Creating a Light Switch in the Heart to Regulate Heart Rate
Often when it is dark, we go for a flashlight or our phone to see where we are going. What if I told you that is much th ...
Loading Comments...